331 related articles for article (PubMed ID: 27273086)
1. Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
Truffault F; de Montpreville V; Eymard B; Sharshar T; Le Panse R; Berrih-Aknin S
Clin Rev Allergy Immunol; 2017 Feb; 52(1):108-124. PubMed ID: 27273086
[TBL] [Abstract][Full Text] [Related]
2. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
3. Thymus involvement in early-onset myasthenia gravis.
Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
[TBL] [Abstract][Full Text] [Related]
4. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
Cron MA; Guillochon É; Kusner L; Le Panse R
Front Immunol; 2020; 11():1074. PubMed ID: 32587589
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.
Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():90-100. PubMed ID: 24389034
[TBL] [Abstract][Full Text] [Related]
7. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
Huang GZ; Lo YL
J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
9. Thymic remodeling associated with hyperplasia in myasthenia gravis.
Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
[TBL] [Abstract][Full Text] [Related]
10. Effect of corticosteroids on the thymus in myasthenia gravis.
Craven C; Reddy PK; Ringel SP; Rutherford RB
Muscle Nerve; 1981; 4(5):425-8. PubMed ID: 7290107
[TBL] [Abstract][Full Text] [Related]
11. [Thymic abnormalities in patients with myasthenia gravis].
Utsugisawa K; Nagane Y
Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
[TBL] [Abstract][Full Text] [Related]
12. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
13. Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis.
Cron MA; Maillard S; Truffault F; Gualeni AV; Gloghini A; Fadel E; Guihaire J; Behin A; Berrih-Aknin S; Le Panse R
Front Immunol; 2019; 10():539. PubMed ID: 30984166
[TBL] [Abstract][Full Text] [Related]
14. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
[TBL] [Abstract][Full Text] [Related]
15. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis.
Sims GP; Shiono H; Willcox N; Stott DI
J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
17. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.
Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P
Front Immunol; 2020; 11():142. PubMed ID: 32210951
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
20. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.
Meraouna A; Cizeron-Clairac G; Panse RL; Bismuth J; Truffault F; Tallaksen C; Berrih-Aknin S
Blood; 2006 Jul; 108(2):432-40. PubMed ID: 16543475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
